OSR Health, Inc. (OSRH) EBITDA (2022 - 2026)
OSR Health (OSRH) posted EBITDA of -$3.7 million for Q1 2026, up 42.57% sequentially from -$6.4 million in Q4 2025, and down 25.68% YoY from -$4.9 million in Q1 2025.
OSR Health, Inc. (OSRH) EBITDA (2022 - 2026) Analysis & Trends
OSR Health has reported EBITDA for 5 years, with the latest figure at -$3.7 million in Q1 2026.
- Quarterly EBITDA fell 25.68% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.1 million (down 68.82% YoY) and the FY2025 annual result came in at -$18.3 million, down 56.85% from the prior year.
- EBITDA rose to -$3.7 million in Q1 2026 per OSRH's latest filing, from -$6.4 million in the prior quarter.
- Over five years, EBITDA peaked at $530029.0 in Q2 2023 and troughed at -$6.4 million in Q4 2025.
- A 5-year average of -$2.0 million and a median of -$2.3 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2024: EBITDA surged 53746.66% in 2023, then slumped 2465.27% in 2024.
- Over 5 years, EBITDA stood at -$14252.0 in 2022, then jumped by 3064.09% to $422442.0 in 2023, then sank by 481.31% to -$1.6 million in 2024, then slumped by 296.41% to -$6.4 million in 2025, then surged by 42.57% to -$3.7 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$3.7 million, -$6.4 million, and -$3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.67 Mn |
| Dec 31, 2025 | -6.39 Mn |
| Sep 30, 2025 | -3.80 Mn |
| Jun 30, 2025 | -5.23 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Dec 31, 2024 | -1.61 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.21 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | 422,442.00 |
| Sep 30, 2023 | 208,068.00 |
| Jun 30, 2023 | 530,029.00 |
| Mar 31, 2023 | 139,626.00 |
| Dec 31, 2022 | -14,252.00 |
| Sep 30, 2022 | -20,022.00 |
| Jun 30, 2022 | -988.00 |